Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

University of Illinois Chicago
Search
University of Illinois Chicago

Office of Continuing Education and Meeting Services

College of Pharmacy - Chicago | Rockford

UI Health is UIC’s academic health enterprise

Trauma – TEG, Anti-Fibrinolytics, Key Considerations (Trauma Management for the Non-Trauma Management Audience)

Posted on September 20, 2021
Brian W. Gilbert, PharmD, BCPS, BCCCP, Ellen C. Omi, MD, MS, FACS

Authors:

Brian W. Gilbert, PharmD, BCPS, BCCCP
Emergency Medicine Clinical Pharmacy Specialist
Residency Program Director, PGY-2 Critical Care
Wesley Medical Center
Adjunct Assistant Clinical Professor
University of Kansas School of Pharmacy

Ellen C. Omi, MD, MS, FACS
Trauma and Surgical Critical Care
Advocate Christ Medical Center
Associate Professor
University of Illinois-Chicago Department of Surgery

Disclosure(s):
Dr. Gilbert, Dr. Omi, and the reviewers who contributed to this activity have no relevant financial relationships of interest to disclose.

Type of Activity: Knowledge-based

Learning Objectives:

  • Discuss different components which comprise thromboelastography (TEG).
  • Evaluate appropriate opportunities in which universal administration of tranexamic acid (TXA) may be efficacious.
  • Explain which TEG abnormalities in which targeted reversal therapies may be beneficial.
  • Describe the classification of hemorrhagic shock based on clinical and objective findings.
  • Describe the role of thromboelastography in the care of the injured patient in hemorrhagic shock.
Target Audience: Pharmacists Fee: $10 (or $45 for all 10 courses). For C4 2021 participants who registered for the live program, please use the access code provided to you by email.
Release Date: September 20, 2021 Expiration Date: September 20, 2023
Estimated Time to Complete: 1 hour CE: 1.0 contact hours (0.1 CEUs)

Go to activity

acpe
Continuing Education Statement: The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned ACPE Universal Activity Number 0016-0000-21-070-H01-P, for 1.0 contact hours (0.1 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test and activity evaluation; estimating duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: https://nabp.pharmacy/programs/cpe-monitor/.

How to Earn Credit:

Participants must complete the activity as described above in the Continuing Education Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on ‘Finish Attempt’, then click on ‘Submit All and Finish’ at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test, a confirmation message will appear at the top of the page underneath your grade. You will have a chance to review the correct answers and answer rationale.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information or questions,  email the Office of Continuing Education and Meeting Services at pharmce@uic.edu. Copyright © 2021– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on March 24, 2023